Cipla unveils drug in Germany
New Delhi: Pharmaceutical major Cipla on Monday launched its generic drug used for treatment of asthma and chronic obstructive pulmonary disease in Germany and Sweden. While the drug Salmeterol/ Fluticasone MDI will be sold under the Serroflo brand in Germany, it will be marketed as Salmeterol/ Fluticasone Cipla in Sweden, Cipla stated. Commenting on the development, Cipla Europe head Frank Pieters said, “With Serroflo we offer in Germany and Sweden an alternative which is effective and efficient and therefore brings many advantages.”